1. Headline
  1. Headline
updated 5/10/2012 4:46:47 PM ET 2012-05-10T20:46:47

Advisers to government health regulators have recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.

A panel of expert advisers to the Food and Drug Administration voted 18-4 to recommend approval of lorcaserin, developed by Arena Pharmaceuticals Inc. They concluded that its benefits "outweigh the potential risks when used long term" in overweight and obese people. One panel member abstained from voting.

Lorcaserin is one of three experimental weight-loss drugs whose developers have been trying for a second time to get approved, after the FDA shot them all down in 2010 or early 2011.

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

More on TODAY.com

  1. Frank Ryland

    Watch this paralyzed groom walk down the aisle at his wedding

    10/21/2014 11:00:13 PM +00:00 2014-10-21T23:00:13
  1. Courtesy of Beau Coffron

    This dad's spooky Halloween lunches will wow you

    10/21/2014 7:31:19 PM +00:00 2014-10-21T19:31:19
  1. Jason Merritt / Getty Images

    Jennifer Garner: No one asks Ben about work-family balance

    10/21/2014 8:58:13 PM +00:00 2014-10-21T20:58:13
  1. Tim Rooke/rex / AP

    Kate's back! Duchess Kate appears for first time since pregnancy news

    10/21/2014 11:57:43 AM +00:00 2014-10-21T11:57:43
  1. Ebola outbreak: West Africans must arrive at 5 US airports

    All travelers from Ebola-stricken countries in West Africa must pass through one of five major U.S. airports with heightened entry screening before entering the country, the Department of Homeland Security said Tuesday.

    10/21/2014 4:22:36 PM +00:00 2014-10-21T16:22:36